Georgia's Online Cancer Information Center

Find A Clinical Trial

Magnetic Resonance Imaging (MRI) Guided Focal Laser Interstitial Thermal Ablation of Localized Prostate Cancer: A Phase II Clinical Trial

Status
Active
Cancer Type
Prostate Cancer
Trial Phase
Phase II
Eligibility
18 Years and older, Male
Study Type
Treatment
NCD ID
NCT03634579
Protocol IDs
RAD4299-18 (primary)
NCI-2018-01001
IRB00094958
Study Sponsor
Emory University Hospital / Winship Cancer Institute

Summary

This phase II trial studies the side effects of magnetic resonance imaging (MRI) guided focal laser ablation and to see how well it works in treating participants with prostate cancer that has not spread to other parts of the body. MRI guided focal laser ablation uses laser fibers under MRI guidance to burn and kill tumors, and may help to improve urinary and rectal continence and erectile function in participants with prostate cancer.

Objectives

PRIMARY OBJECTIVES:
I. To determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer.

OUTLINE:
Participants undergo MRI guided focal laser ablation.

After completion of study treatment, participants are followed up at 3 weeks, 3 and 6 months, and 1 and 2 years.
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.